BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/9/2026 4:15:46 AM | Browse: 1 | Download: 1
Publication Name World Journal of Gastroenterology
Manuscript ID 123490
Country China
Received
2026-05-20 07:52
Peer-Review Started
2026-05-20 07:52
First Decision by Editorial Office Director
2026-06-04 09:04
Return for Revision
2026-06-04 09:04
Revised
2026-06-15 09:38
Publication Fee Transferred
2026-06-20 13:15
Second Decision by Editor
2026-07-02 02:34
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-07-02 08:48
Articles in Press
2026-07-02 08:48
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-09-14 03:08
Publish the Manuscript Online
2026-11-09 04:15
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Basic Study
Article Title Identification of UPB1 as a tumor suppressor associated with immune infiltration in cholangiocarcinoma
Manuscript Source Unsolicited Manuscript
All Author List Zhong-Hai Sun, Bi-Cheng Zeng, Jia Sun, Bing-Lu Li and Zu-Yi Ma
ORCID
Author(s) ORCID Number
Bing-Lu Li http://orcid.org/0000-0002-9142-0793
Zu-Yi Ma http://orcid.org/0000-0002-8517-7600
Funding Agency and Grant Number
Funding Agency Grant Number
Scientific Research Promotion Program for Clinical Medicine No. 2025CMFA08
Beijing Bethune Charitable Foundation No. GDZL040
Postdoctoral Fellowship Program of China Postdoctoral Science Foundation No. GZC20251430
Sun Yat-sen Pilot Scientific Research Fund No. YXQH202608
Corresponding Author Zu-Yi Ma, Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, No. 107 Yanjiang West Road, Yuexiu District, Guangzhou 510000, Guangdong Province, China. 13076335286@163.com
Key Words UPB1; Cholangiocarcinoma; Tumor suppressor; Immune infiltration; Cell cycle; Apoptosis
Core Tip This study identifies UPB1 as a tumor suppressor in cholangiocarcinoma (CCA). The expression of UPB1 is downregulated in CCA and correlates with adverse clinical features and worse survival. UPB1 overexpression enhances cell apoptosis and triggers G1/S phase arrest. UPB1 expression shows a positive correlation with tumor-infiltrating lymphocytes, and UPB1 overexpression promotes T-cell activation and immune factor release. UPB1 represents a novel prognostic biomarker and a candidate for further investigation in CCA.
Publish Date 2026-11-09 04:15
Citation

Sun ZH, Zeng BC, Sun J, Li BL, Ma ZY. Identification of UPB1 as a tumor suppressor associated with immune infiltration in cholangiocarcinoma. World J Gastroenterol 2027; 33(1): 123490

URL https://www.wjgnet.com/1007-9327/full/v33/i1/123490.htm
DOI https://doi.org/10.3748/wjg.123490
Full Article (PDF) WJG-33-123490-with-cover.pdf